Effectiveness of acupuncture in managing aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis

Objective: Breast cancer is the second most prevalent cause of mortality in women and the predominant malignancy type. However, breast cancer treatment faces challenges in managing aromatase inhibitor-induced arthralgia. Aromatase inhibitors have been shown to decrease recurrence risk in hormone receptor-positive cases; however, joint discomfort remains the primary adverse effect. Randomized clinical trials have evaluated the therapeutic outcomes of acupuncture for medication-related musculoskeletal complications. This comprehensive analysis sought to elucidate both the therapeutic efficacy and placebo responses associated with acupuncture intervention. Methods: Two reviewers searched for randomized controlled trials (RCTs) in four English (PubMed, Embase, Web of Science, and the Cochrane Library) and four Chinese databases (CNKI, Wanfang Database, VIP, and SinoMed) from their inception to May 31, 2024. Methodological quality was assessed using the Cochrane risk of bias tool. Data were synthesized using random effects models and presented with forest plots. Results: Seven trials involving 604 patients were included. The primary outcome and Brief Pain Inventory (BPI) score differed between the acupuncture and control groups (sham acupuncture or usual medication) in three subscales over the course of 6 weeks: worst pain: standardized mean difference (SMD) = −1.18, 95% confidence interval (CI): −1.74, −0.63, P < 0.001; pain-related interference: SMD = −0.87, 95% CI: −1.70, −0.05, P = 0.038; pain severity: SMD = −0.63, 95% CI: −1.22, −0.04, P = 0.036. No severe adverse events were reported in any study. Conclusions: This meta-analysis showed that acupuncture is a safe and effective treatment for patients with breast cancer with aromatase inhibitor-induced arthralgia during the course of 6 weeks. Improvements in the blinding method and clarification of the total treatment recommendations and intervals need to be explored further.

Authors

Institutions

Publication Details

Journal
Acupuncture and Herbal Medicine
Published
2025-09-01
DOI
https://doi.org/10.1097/hm9.0000000000000172
Citations
7
Primary Topic
Acupuncture Treatment Research Studies
Type
article
Field-Weighted Citation Impact
16.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of acupuncture in managing aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis

Lu Yong, Xinru Yuan, Peihong Ma, Yifeng Zheng et al.
7 citations
Acupuncture and Herbal Medicine
Acupuncture Treatment Research Studies
16.67
article

Effectiveness of acupuncture in managing aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis

Lu Yong, Xinru Yuan, Peihong Ma, Yifeng Zheng, Baomin Dou, Zheng Zhu, Liang Liu, Bo Chen, Zelin Chen, Yi Guo, Aoxiang Chen
article en
7 citations

Abstract

Objective: Breast cancer is the second most prevalent cause of mortality in women and the predominant malignancy type. However, breast cancer treatment faces challenges in managing aromatase inhibitor-induced arthralgia. Aromatase inhibitors have been shown to decrease recurrence risk in hormone receptor-positive cases; however, joint discomfort remains the primary adverse effect. Randomized clinical trials have evaluated the therapeutic outcomes of acupuncture for medication-related musculoskeletal complications. This comprehensive analysis sought to elucidate both the therapeutic efficacy and placebo responses associated with acupuncture intervention. Methods: Two reviewers searched for randomized controlled trials (RCTs) in four English (PubMed, Embase, Web of Science, and the Cochrane Library) and four Chinese databases (CNKI, Wanfang Database, VIP, and SinoMed) from their inception to May 31, 2024. Methodological quality was assessed using the Cochrane risk of bias tool. Data were synthesized using random effects models and presented with forest plots. Results: Seven trials involving 604 patients were included. The primary outcome and Brief Pain Inventory (BPI) score differed between the acupuncture and control groups (sham acupuncture or usual medication) in three subscales over the course of 6 weeks: worst pain: standardized mean difference (SMD) = −1.18, 95% confidence interval (CI): −1.74, −0.63, P < 0.001; pain-related interference: SMD = −0.87, 95% CI: −1.70, −0.05, P = 0.038; pain severity: SMD = −0.63, 95% CI: −1.22, −0.04, P = 0.036. No severe adverse events were reported in any study. Conclusions: This meta-analysis showed that acupuncture is a safe and effective treatment for patients with breast cancer with aromatase inhibitor-induced arthralgia during the course of 6 weeks. Improvements in the blinding method and clarification of the total treatment recommendations and intervals need to be explored further.

Acupuncture and Herbal MedicineVol. 5(3)
Rutgers, The State University of New Jersey (US), Tianjin University of Traditional Chinese Medicine (CN), INTI International University (MY), Tianjin Medical University Cancer Institute and Hospital (CN), First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN), Center for Cancer Research (US)
Openalex Percentile: Top 1%
Acupuncture Treatment Research Studies
16.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.